International Journal of Clinical Oncology

, Volume 24, Issue 5, pp 494–500 | Cite as

Interaction of H. pylori with toll-like receptor 2-196 to -174 ins/del polymorphism is associated with gastric cancer susceptibility in southern China

  • Jin Huang
  • Jun-Jie Hang
  • Xiang-Rong Qin
  • Jian Huang
  • Xiao-Yong WangEmail author
Original Article



Genetic polymorphisms of Toll-like receptors play important roles in gastric carcinogenesis. The aim of this study was to determine the role of TLR2-196 to -174 ins/del polymorphism in gastric cancer susceptibility and prognosis.


This study included 520 people from southern China. Samples were genotyped by the allele-specific polymerase chain reaction, among which 10% were randomly selected for sequencing. The serological method was used to determine Helicobacter pylori.


The TLR2 genotype was not associated with the risk of H. pylori infection. The del/del genotype exhibited significantly higher gastric cancer risk (adjusted OR 2.59, 95% CI 1.33‒5.07) than that of the ins/ins genotype. Further stratification analyses demonstrated that the del/del genotype was associated with a risk of intestinal gastric cancer (adjusted OR 2.62, 95% CI 1.34–5.14). In addition, the presence of the del/del genotype and the H. pylori infection conferred a synergistic effect (OR 3.04, 95% CI 1.33‒6.98) for the development of gastric cancer. The del/del genotype was not associated with a poor prognosis in gastric cancer patients.


The del/del genotype is associated with an increased gastric cancer risk in the southern Chinese population. However, TLR2 polymorphism is neither associated with H. pylori infection, nor with a poor prognosis.


H. pylori Gastric cancer Prognosis TLR2 Polymorphism 



This study was supported by the Applied Basic Research Fund of Changzhou, China (CJ20140022, CJ20179034), Young medical talents of Jiangsu province (QNRC2016269), the High-level Medicine Talents Training Project (2016CZBJ022), and the Youth Science and Technology Project of Changzhou Health and Family Planning Commission (QN201601).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.


  1. 1.
    Torre LA, Bray F, Siegel RL et al (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108CrossRefGoogle Scholar
  2. 2.
    Chen W, Zheng R, Zhang S et al (2017) Cancer incidence and mortality in China, 2013. Cancer Lett 401:63–71CrossRefGoogle Scholar
  3. 3.
    Gobert AP, Wilson KT (2017) Human and Helicobacter pylori interactions determine the outcome of gastric diseases. Curr Top Microbiol Immunol 400:27–52PubMedCentralGoogle Scholar
  4. 4.
    Lochhead P, El-Omar EM (2007) Helicobacter pylori infection and gastric cancer. Best Pract Res Clin Gastroenterol 21(2):281–297CrossRefGoogle Scholar
  5. 5.
    Hold GL, Rabkin CS, Chow WH et al (2007) A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology 132(3):905–912CrossRefGoogle Scholar
  6. 6.
    Barton GM (2008) A calculated response: control of inflammation by the innate immune system. J Clin Invest 118(2):413–420CrossRefPubMedCentralGoogle Scholar
  7. 7.
    Akira S, Hemmi H (2003) Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett 85(2):85–95CrossRefGoogle Scholar
  8. 8.
    Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4(7):499–511CrossRefGoogle Scholar
  9. 9.
    Pimentel-Nunes P, Afonso L, Lopes P et al (2011) Increased expression of toll-like receptors (TLR) 2, 4 and 5 in gastric dysplasia. Pathol Oncol Res 17(3):677–683CrossRefGoogle Scholar
  10. 10.
    Nemati M, Larussa T, Khorramdelazad H et al (2017) Toll-like receptor 2: An important immunomodulatory molecule during Helicobacter pylori infection. Life Sci 178:17–29CrossRefGoogle Scholar
  11. 11.
    Smith MF Jr, Mitchell A, Li G et al (2003) Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-kappa B activation and chemokine expression by epithelial cells. J Biol Chem 278(35):32552–32560CrossRefGoogle Scholar
  12. 12.
    Haehnel V, Schwarzfischer L, Fenton MJ et al (2002) Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages. J Immunol 168(11):5629–5637CrossRefGoogle Scholar
  13. 13.
    Chen YC, Hsiao CC, Chen CJ et al (2010) Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts. BMC Med Genet 30:11:17CrossRefGoogle Scholar
  14. 14.
    Takeda K, Kaisho T, Akira S (2003) Toll-like receptors. Annu Rev Immunol 21:335–376CrossRefGoogle Scholar
  15. 15.
    Noguchi E, Nishimura F, Fukai H et al (2004) An association study of asthma and total serum immunoglobin E levels for toll-like receptor polymorphisms in a Japanese population. Clin Exp Allergy 34(2):177–183CrossRefGoogle Scholar
  16. 16.
    Theodoropoulos GE, Saridakis V, Karantanos T et al (2012) Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development. Breast 21(4):534–538CrossRefGoogle Scholar
  17. 17.
    Nischalke HD, Coenen M, Berger C et al (2012) The toll-like receptor 2 (TLR2)-196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C. Int J Cancer 130(6):1470–1475CrossRefGoogle Scholar
  18. 18.
    Srivastava K, Srivastava A, Kumar A et al (2010) Significant association between toll-like receptor gene polymorphisms and gallbladder cancer. Liver Int 30(7):1067–1072CrossRefGoogle Scholar
  19. 19.
    Tahara T, Arisawa T, Wang F et al (2007) Toll-like receptor 2-196 to -174del polymorphism influences the susceptibility of Japanese people to gastric cancer. Cancer Sci 98(11):1790–1794CrossRefGoogle Scholar
  20. 20.
    Zeng HM, Pan KF, Zhang Y et al (2011) Genetic variants of toll-like receptor 2 and 5, Helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population. Cancer Epidemiol Biomarkers Prev 20(12):2594–2602CrossRefGoogle Scholar
  21. 21.
    Wang X, Yang Y, Shi R et al (2008) An evaluation of a serologic test with a current infection marker of Helicobacter pylori before and after eradication therapy in Chinese. Helicobacter 13:49–55CrossRefGoogle Scholar
  22. 22.
    Hishida A, Matsuo K, Goto Y et al (2010) No associations of Toll-like receptor 2 (TLR2)-196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese. Gastric Cancer 13(4):251–257CrossRefGoogle Scholar
  23. 23.
    Chen B, Luo MX, Zhou X et al (2016) Correlation between interleukin-1β-511 C/T polymorphism and gastric cancer in Chinese populations: a meta-analysis. Med Sci Monit 24(22):1742–1750CrossRefGoogle Scholar
  24. 24.
    van der Stoep N, Quinten E, van den Elsen PJ (2002) Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5′-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes. J Immunol 169(9):5061–5071CrossRefGoogle Scholar
  25. 25.
    van der Velden AW, Thomas AA (1999) The role of the 5′ untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 31(1):87–106CrossRefGoogle Scholar
  26. 26.
    Li S, Cao M, Song L et al (2016) The contribution of toll-like receptor 2 on Helicobacter pylori activation of the nuclear factor-kappa B signaling pathway in gastric epithelial cells. Microb Pathog 98:63–68CrossRefGoogle Scholar
  27. 27.
    Parsonnet J, Friedman GD, Vandersteen DP et al (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325(16):1127–1131CrossRefGoogle Scholar
  28. 28.
    Wang F, Meng W, Wang B et al (2014) Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett 345(2):196–202CrossRefGoogle Scholar
  29. 29.
    Marqués-Lespier JM, González-Pons M, Cruz-Correa M (2016) Current perspectives on gastric cancer. Gastroenterol Clin North Am 45(3):413–428CrossRefPubMedCentralGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2018

Authors and Affiliations

  1. 1.Department of GastroenterologyChangzhou No. 2 People’s HospitalChangzhouChina
  2. 2.Department of OncologyChangzhou No. 2 People’s HospitalChangzhouChina

Personalised recommendations